Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Anticancer Research|June 9, 2016
Distance from Primary Tumor Is the Strongest Predictor for Early Onset of Brain Metastases in MelanomaEszter Gorka, Dániel Fabó, András Gézsi, et al.
Orvosi Hetilap|September 3, 2023
[Electrochemotherapy in metastatic melanoma]Mihály Kispál, Kata Czirbesz, Fanni Baranyai, et al.
Pathology Oncology Research : POR|June 2, 2017
Dabrafenib Therapy in 30 Patients with Melanoma Metastatic to the Brain: a Single-centre Controlled Retrospective Study in HungaryEszter Gorka, Dániel Fabó, András Gézsi, et al.
Cancers|July 2, 2021
Predictive and Prognostic Value of BRAF and NRAS Mutation of 159 Sentinel Lymph Node Cases in Melanoma-A Retrospective Single-Institute StudyGabriella Liszkay, Zoltán Mátrai, Kata Czirbesz, et al.
Cancers|November 13, 2025
Real-World Outcomes of Ipilimumab-Nivolumab vs. Anti-PD-1 Monotherapy in Metastatic Uveal Melanoma: A Single-Center Retrospective StudyGitta Pánczél, Patrik Horváth, Erijona Temaj, et al.
Cancers|July 12, 2025
Characterization of Melanoma in Hungary Based on a Retrospective Single-Center Study Between 2001 and 2018Renáta Gubán, Petra Parrag, Mihály Tamás Kispál, et al.
Pathology Oncology Research : POR|October 1, 2017
Efficacy of Vemurafenib Treatment in 43 Metastatic Melanoma Patients with BRAF Mutation. Single-Institute Retrospective Analysis, Early Real-Life Survival DataKata Czirbesz, Eszter Gorka, Tímea Balatoni, et al.
Magyar Onkologia|June 20, 2022
[BRAF-MEK inhibitor therapy in melanoma]Kata Czirbesz, Gitta Pánczél, Fanni Baranyai, et al.
Pathology Oncology Research : POR|September 19, 2018
Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with IpilimumabTímea Balatoni, Andrea Ladányi, Georgina Fröhlich, et al.
Magyar Onkologia|March 3, 2016
[Psychological aspects of immunotherapies in the treatment of malignant melanoma]Péter Kovács, Gitta Pánczél, Krisztina Melegh, et al.
Pageof 2